European Commission calls out Teva over anti-competitive practice

18-07-2017

European Commission calls out Teva over anti-competitive practice

slavemotion / iStockphoto.com

The European Commission has called out Teva over anti-competitive behaviour centring on a pay-for-delay drug deal.


European Commission, Teva, anti-competition, modafinil, EEA, Cephalon, pay-for-delay

LSIPR